Zoom image
Geneva, a pioneer in precision cancer medicine
The challenge
Every tumour is unique. Analysing their DNA can help identify the mutation(s) responsible and tailor patient care, even when standard treatments have failed. But how should such complex and sensitive data be managed and interpreted?
The solution
At the HUG, theOncobench® bioinformatics platform is integrated directly into the hospital and has been in clinical use since 2016. It analyses patients’ tumour molecular profiles whilst evolving in line with advances in research.
The impact
More accurate diagnoses and treatments tailored to each patient, with secure health data within the hospital.
Patient
Did you know?
Oncobench® is the result of a collaboration spanning more than ten years between the Geneva University Hospitals (HUG) and SIB. The platform has made the HUG a pioneer in genomic medicine.